Faraday Pharmaceuticals is a biopharmaceutical company focused on the research and development of elemental reducing agents. These therapeutic agents have potential applications for treatment of critical care illnesses.
Location: United States, Washington, Seattle
Total raised: $25M
Investors 3
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| 10.07.2026 | The Univer... | ut-ec.co.j... |
| - | WRF Capita... | wrfseattle... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.09.2019 | - | $25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 20.09.2019 | Fred Hutch spinout Faraday Pharmaceuticals raises $25M for muscle loss prevention drug | The Faraday team. (Faraday Photo) When a patient is bedridden during a hospital stay, they can lose muscle mass at a rapid clip, compounding problems from their original illness. But what if there was a way to prevent that muscle loss from ... |
| 02.04.2019 | Seattle Venture Capital Watch: Crelate, Cyemptive, Blue Canoe & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Businesses developing software to assist recruiters, corporate IT departments, and people learning to speak English are among the Seattle-area companies that have in recent we... |
| 05.04.2017 | VCs Poured $300M into Seattle Area Companies in Q1, Up 33 Percent | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Seattle-area companies collected some $300 million in investment during the first quarter, with biotech and medical devices companies claiming four of the 10 largest deals. Th... |
| - | Faraday Pharmaceuticals | “Faraday Pharmaceuticals is a biopharmaceutical company focused on the research and development of elemental reducing agents. These therapeutic agents have potential applications for treatment of critical care illnesses.” |